For SARS-CoV entry, which is reported to be highly CatL-dependent, it has been shown that expression of the cellular transmembrane protease serine 2 (TMPRSS2) can overcome the block in SARS-CoV infection and replication caused by CatL inhibitors [42]–[45]. The gene discussed is CTSL; the disease is severe acute respiratory syndrome.